Objective
To describe, with a larger number of patients in a real-world scenario
following routine implementation, intensivist-led ultrasound-guided
percutaneous dilational tracheostomy and the possible risks and
complications of the procedure not identified in clinical trials.
Methods
This was a phase IV cohort study of patients admitted to three intensive care
units of a quaternary academic hospital who underwent intensivist-led
ultrasound-guided percutaneous tracheostomy in Brazil from September 2017 to
December 2021.
Results
There were 4,810 intensive care unit admissions during the study period;
2,084 patients received mechanical ventilation, and 287 underwent
tracheostomy, 227 of which were performed at bedside by the intensive care
team. The main reason for intensive care unit admission was trauma, and for
perform a tracheostomy it was a neurological impairment or an inability to
protect the airways. The median time from intubation to tracheostomy was 14
days. Intensive care residents performed 76% of the procedures. At least one
complication occurred in 29.5% of the procedures, the most common being
hemodynamic instability and extubation during the procedure, with only 3
serious complications. The intensive care unit mortality was 29.1%, and the
hospital mortality was 43.6%.
Conclusion
Intensivist-led ultrasound-guided percutaneous tracheostomy is feasible out
of a clinical trial context with outcomes and complications comparable to
those in the literature. Intensivists can acquire this competence during
their training but should be aware of potential complications to enhance
procedural safety.